Decreased viability and neurite length in neural cells treated with chitosan-dextran sulfate nanocomplexes

Abstract

CXCL12 is a chemokine known to regulate migration, proliferation, and differentiation of neural stem cells (NSCs) and to play a neuroprotective role in ischemic stroke. Chitosan-dextran sulfate nanocomplexes (Ch/DS NC) are known nanoparticulated systems used to efficiently deliver heparin-binding factors. Here we evaluate Ch/DS NC as carriers for CXCL12 in a model of stroke, and, surprisingly, found evidence of Ch/DS NC-induced brain lesion.Neurotoxic screening revealed that Ch/DS NC reduced neuronal viability, decreased the extension of neurites and impaired neural stem cell migration in vitro. Adding CXCL12 to the complexes attenuated these effects, but did no reverse it. To the best of our knowledge, neurotoxicity of Ch/DS NC has not been reported and further screenings will be needed in order to evaluate the biological safety of these nanocomposites. Our results add new data on nanoparticle neurotoxicity and may help us to better understand the complex interactions of the nanostructures with biological components. Highlights:1. Chitosan-dextran sulfate nanocomplexes (Ch/DS NC) increased stroke volume in vivo; Ch/DS NC reduced neural cells viability in vitro;3. Ch/DS NC altered neural cells morphology in vitro; 4. Adding CXCL12 to Ch/DS NC attenuated these effects, but did no reverse it.